IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Cell Point (India) IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Visakhapatnam and caters to Electric Equipments sector. First Overseas Capital is the merchant banker of Cell Point (India) IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 20th March 2023.
Cell Point (India) IPO posted revenues of Rs 295.57 crores and PAT of Rs 7.75 crores in FY23 on annualised basis.Financial results of Cell Point (India) IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Cell Point (India) IPO PAT Margin is 2.63%, ROCE (Return on Capital Employed) is 18.13% as per latest financial. The below table shows Cell Point (India) IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Cell Point (India) IPO is Rs 186.86 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Cell Point (India) IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Cell Point (India) IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Cell Point (India) IPO is ₹186.86 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Cell Point (India) IPO has a Price-to-Earnings (PE) ratio of 24.10 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Cell Point (India) IPO reported revenue of ₹295.57 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Cell Point (India) IPO provide insights into sales growth, market demand, and business scalability.
Cell Point (India) recorded an EBITDA of ₹ 18.41 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Cell Point (India) Profit After Tax (PAT) is ₹7.73 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 294.31 Cr.
EBITDA Margin:
6.26
%
Net Worth: ₹ 19.16 Cr.
Market Capitalisation:
₹ 186.86 Cr.
P/E:
24.10 times
P/BV: 2.69 times
EV/EBITDA: 12.80 times
Cell Point (India) operates in Electric Equipments and Multi-brand Retail Selling Of Smart Phones, Tablets, Mobile Accessories. The Issue is listed on NSE EMERGE in Jun, 2023. Cell Point (India) IPO size was 50.34 with Issue price of 100.00 .
Merchant Banker(s) of Cell Point (India) IPO: First Overseas Capital Limited
Cell Point (India) IPO subscription was 6.03 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Cell Point (India) IPO listed at a listing price of 100.00 against the offer price of 100.00.
The current market price of Cell Point (India) is 19.15.
Why Us?
